CompanyNYSEDover, DE

BiomX Inc

SEC EDGAR ClinicalTrials.gov

424B3Nov 3Latest SEC filing

Form DJan 20$3.3M sold

October 2026

Tessera issues more shares to Mandragola on DFSL warrant exercises

Oct 23FinancingBiomX IncUpdated

Tessera signs CEO employment pact with Michael Oster, ties pay to EBITDA targets

Oct 7PeopleBiomX Inc

Tessera Defense secures new $5 million credit line from Mandragola

Oct 5FinancingBiomX Inc